tiprankstipranks
Advertisement
Advertisement

ELTX Stock Latest News

Elicio Therapeutics reports inducement grants
The FlyElicio Therapeutics reports inducement grants
7d ago
ELTX
Elicio Therapeutics Launches New $100 Million ATM Program
PremiumCompany Announcements
Elicio Therapeutics Launches New $100 Million ATM Program
8d ago
8K
ELTX
Elicio Therapeutics price target raised to $17 from $13 at H.C. Wainwright
PremiumThe Fly
Elicio Therapeutics price target raised to $17 from $13 at H.C. Wainwright
11d ago
ELTX
Elicio Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Elicio Therapeutics initiated with a Buy at Rodman & Renshaw
15d ago
ELTX
Elicio Therapeutics files $400M mixed securities shelf
PremiumThe Fly
Elicio Therapeutics files $400M mixed securities shelf
25d ago
ELTX
Elicio Therapeutics reports inducement grants
PremiumThe FlyElicio Therapeutics reports inducement grants
1M ago
ELTX
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
2M ago
ELTX
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
3M ago
ELTX
Elicio Therapeutics’ ELI-002 7P shows antigen spreading in Phase 2 trial
PremiumThe Fly
Elicio Therapeutics’ ELI-002 7P shows antigen spreading in Phase 2 trial
3M ago
ELTX
Elicio Therapeutics appoints Marc Wolfgang as CTO
PremiumThe Fly
Elicio Therapeutics appoints Marc Wolfgang as CTO
4M ago
ELTX
Elicio Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Elicio Therapeutics Reports Q3 2025 Financial Results
4M ago
ELTX
Elicio Therapeutics files to sell 103,225 shares of common stock for holders
PremiumThe Fly
Elicio Therapeutics files to sell 103,225 shares of common stock for holders
4M ago
ELTX
Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
PremiumThe FlyElicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
5M ago
ELTX
Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
Premium
The Fly
Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
5M ago
ELTX
Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P
Premium
The Fly
Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P
6M ago
ELTX
Elicio Therapeutics reports inducement grants
PremiumThe Fly
Elicio Therapeutics reports inducement grants
6M ago
ELTX
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results
PremiumCompany Announcements
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results
6M ago
8K
ELTX
Elicio reports ELI-002 7P induced T cell responses in 99% of patients
PremiumThe Fly
Elicio reports ELI-002 7P induced T cell responses in 99% of patients
6M ago
ELTX
Elicio Therapeutics Publishes Promising Phase 1 Study Data
PremiumCompany Announcements
Elicio Therapeutics Publishes Promising Phase 1 Study Data
7M ago
8K
ELTX
Elicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
PremiumThe FlyElicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
7M ago
ELTX
Elicio Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Elicio Therapeutics Reports Q2 2025 Financial Results
7M ago
ELTX
Elicio Therapeutics Advances Phase 2 AMPLIFY-7P Study
Premium
Company Announcements
Elicio Therapeutics Advances Phase 2 AMPLIFY-7P Study
8M ago
8K
ELTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >